Metraipolis › archive › dc_d9145697a210

Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3… — Europe PMC PMID:41257453

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41257453
DOI
10.1002/clt2.70121
License (as archived)
solo-consultazione
Archived
2026-11-08T20:58:45.828Z
SHA-256 of the archived text
f574ef32ec98e4342ec3c6f3378abc3edcd358890a54dd3a9167a1a8a4b306b6
Stable URL of this page
https://metraipolis.com/documento/dc_d9145697a210

How to cite

Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3… — Europe PMC PMID:41257453 — Europe PMC (en), https://europepmc.org/article/MED/41257453 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d9145697a210 (Metraipolis archive dc_d9145697a210, sha256 f574ef32ec98e4342ec3c6f3378abc3edcd358890a54dd3a9167a1a8a4b306b6)
BibTeX
@misc{dcd9145697a210,
  title = {Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3… — Europe PMC PMID:41257453},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41257453},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d9145697a210; sha256 f574ef32ec98e4342ec3c6f3378abc3edcd358890a54dd3a9167a1a8a4b306b6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41257453. Agents can read the archived copy with the MCP tool read_document.